Pulmonx Corp [NASDAQ: LUNG] slipped around -1.31 points on Thursday, while shares priced at $1.84 at the close of the session, down -41.59%.
Compared to the average trading volume of 405.00K shares, LUNG reached a trading volume of 4620858 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Pulmonx Corp [LUNG]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LUNG shares is $7.42 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LUNG stock is a recommendation set at 1.67. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Pulmonx Corp shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on Aug-01-25. While these analysts kept the previous recommendation, D. Boral Capital raised their target price to Buy. The new note on the price target was released on March 10, 2025, representing the official price target for Pulmonx Corp stock. Previously, the target price had yet another drop from $17 to $7.50, while Citigroup kept a Neutral rating on LUNG stock.
The Price to Book ratio for the last quarter was 0.95, with the Price to Cash per share for the same quarter was set at 2.10.
How has LUNG stock performed recently?
Pulmonx Corp [LUNG] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -44.49. With this latest performance, LUNG shares dropped by -31.60% in over the last four-week period, additionally sinking by -68.44% over the last 6 months – not to mention a drop of -72.90% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LUNG stock in for the last two-week period is set at 30.29, with the RSI for the last a single of trading hit 0.43, and the three-weeks RSI is set at 0.35 for Pulmonx Corp [LUNG]. The present Moving Average for the last 50 days of trading for this stock 2.97, while it was recorded at 2.90 for the last single week of trading, and 5.49 for the last 200 days.
Pulmonx Corp [LUNG]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Pulmonx Corp [LUNG] shares currently have an operating margin of -62.85% and a Gross Margin at 73.07%. Pulmonx Corp’s Net Margin is presently recorded at -62.88%.
Pulmonx Corp (LUNG) Capital Structure & Debt Analysis
According to recent financial data for Pulmonx Corp. ( LUNG), the Return on Equity (ROE) stands at -66.88%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -35.61%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Pulmonx Corp’s Return on Invested Capital (ROIC) is -45.66%, showcasing its effectiveness in deploying capital for earnings.
Pulmonx Corp (LUNG) Efficiency & Liquidity Metrics
Based on Pulmonx Corp’s (LUNG) latest financial statements, the Debt-to-Equity Ratio is 0.82%, indicating its reliance on debt financing relative to shareholder equity.
Pulmonx Corp (LUNG) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Pulmonx Corp. (LUNG) effectively leverages its workforce, generating an average of -$195670.1 per employee. The company’s liquidity position is robust, with a Current Ratio of 5.35% and a Quick Ratio of 4.63%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Pulmonx Corp [LUNG]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for LUNG. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Pulmonx Corp go to 16.98%.
Insider trade positions for Pulmonx Corp [LUNG]
There are presently around $91.90%, or 96.13%% of LUNG stock, in the hands of institutional investors. The top three institutional holders of LUNG stocks are: PRIMECAP MANAGEMENT CO/CA/ with ownership of 5.71 million shares, which is approximately 14.6622%. FMR LLC, holding 5.28 million shares of the stock with an approximate value of $$33.48 million in LUNG stocks shares; and FMR LLC, currently with $$22.01 million in LUNG stock with ownership which is approximately 8.9132%.
